Tag: by

Newborns impacted by moms’ lack of health literacy

Healthy mom, healthy baby. The concept sounds simple enough, but a recent Northwestern Medicine study found the level of health literacy—how someone obtains, uses and understands health information—among pregnant people isn’t where it needs to be, and it’s having a negative impact on babies in utero and after birth, especially among people of color. Of

Parent, child well-being affected by schooling mode during COVID-19

Children not receiving in-person school instruction and their parents have worse mental, emotional, and physical health outcomes, according to research published in the March 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Jorge V. Verlenden, Ph.D., from the CDC in Atlanta, and colleagues examined differences in child

US to distribute 4 million J&J COVID vaccines by Tuesday

Four million doses of the latest COVID-19 vaccine to get US approval will be delivered across the country as early as Tuesday, a senior administration official said. The United States on Saturday authorized Johnson & Johnson’s COVID vaccine for emergency use, boosting President Joe Biden’s plan to battle the outbreak that has killed more than

Doctors reverse jumping vision caused by light deprivation

Gradual exposure to light restored vision to a migraine sufferer who developed miner’s nystagmus after an extended period of severe light deprivation, reports a team led by UCL experts. Nystagmus is characterized by involuntary eye movements causing jumping and blurred vision, and is sometimes known as wobbly eyes or jerky eyes. Miner’s nystagmus is a

Iran expects first batch of Russian vaccine by Feb 4

Iran’s ambassador to Russia said Saturday that Tehran expects to receive the first batch of Moscow’s Sputnik V coronavirus vaccine by February 4, state news agency IRNA reported. The news comes just days after Iran’s Foreign Minister Mohammad Javad Zarif announced the vaccine had been approved by the Islamic republic. “A contract for the purchase

New mutant coronavirus strain IS more contagious by nearly 50%

New Kent strain of ‘super-COVID’ is nearly 50 percent more contagious than other varieties, Imperial study confirms Imperial College London researchers analyzed how quickly the new B117 ‘super-COVID’ variant spreads They compared samples of the mutated virus taken from nearly 2,000 people in  the UK to another  84,000 taken from people with other variants B117

After months of calm, Thailand challenged by virus outbreak

After managing against the odds to keep the coronavirus largely in check for most of the year, Thailand has suddenly found itself challenged by an expanding outbreak among migrant workers on the doorstep of the capital, Bangkok. The surge of cases in Samut Sakhon province threatens to undo months of efforts to contain the virus

New LawAtlas data show widespread preemption efforts by US states in policy domains that could improve health

Across the US, states are increasingly using preemption to stymie local advancement of public health policy strategies, according to updated data released today to LawAtlas.org by the Center for Public Health Law Research and the National League of Cities with support from the Robert Wood Johnson Foundation. The updated data capture state preemption of local

Improving vaccination rates by dispelling mistrust and conspiracy

A leading University of Queensland academic is using his research to improve vaccination rates across the country. Dr. Tom Aechtner from UQ’s School of Historical and Philosophical Inquiry has launched the world’s first Massive Open Online Couse (MOOC), AVAXX101, dedicated to anti-vaccination and vaccine hesitancy. This MOOC works alongside a website, UQVaccinationChoice, to provide impartial

US COVID vaccinations could start by Monday: health secretary

The United States could start injecting the first Americans with the Pfizer-BioNTech COVID-19 vaccine by Monday, the country’s health secretary said Friday. Alex Azar told news channels that final details were being ironed out, after an expert committee convened by regulators voted to grant the two-dose regimen emergency approval for people aged 16 and over.